The life sciences industry operates within a complex and changing regulatory environment. Submission requirements are more demanding, and timelines are tighter. Additionally, companies increasingly need their regulatory documentation to be translated into multiple languages and jurisdictions simultaneously. That is exactly the challenge this new regulatory writing and localization partnership between Vistatec Life Sciences and Global Regulatory Writing & Consulting (GLOBAL) is built to address.
Two Established Players, One Integrated Solution
Vistatec Life Sciences and GLOBAL have worked together on client projects for many years. This formalized partnership takes that proven working relationship and structures it into something clients can rely on from the outset.
GLOBAL brings deep regulatory expertise to the table. Their in-house team of specialist writers produces clinical, regulatory, and GMP documentation at every stage of the product development lifecycle. That work includes pre-market submissions, post-approval maintenance, and everything in between. They work across both drug and device categories, with particular strength in areas like 510(k) submissions, IND/NDA filings, and EU MDR compliance.
Vistatec Life Sciences complements this with multilingual regulatory precision at scale. Their portfolio spans medical devices, clinical trials, biotechnology, pharmaceuticals, health care software, and mental health. Vistatec’s localization expertise ensures that regulated content can move confidently across languages, regions, and regulatory authorities. Furthermore, Vistatec’s quality and governance-ready translations mean fewer surprises during regulatory review.
A World-Class Regulatory Writing and Localization Partnership
Traditionally, life sciences organizations have had to manage separate vendors for regulatory writing and translation. That fragmented approach creates real problems. Each handoff between providers introduces the risk of inconsistency. In turn, every inconsistency can trigger additional review cycles, delays, and compliance questions. For companies operating across markets, the complexity multiplies.
This partnership directly addresses these requirements. Instead of coordinating between a writing team and a separate translation provider, clients can access both capabilities through a single, integrated solution. As a result, content is written for regulatory accuracy from the start and translated with the same level of precision and compliance awareness.
What Customers Can Expect
The partnership delivers four tangible benefits for life sciences organizations.
Faster time to market
When writing and translation workflows are aligned, downstream delays shrink. Content moves through the pipeline more efficiently, and regulatory approval timelines tighten as a result.
Fewer review cycles
Regulatory authorities expect clear, accurate, and consistent documentation. When writing and localization teams work from the same foundation, the content is more likely to meet those standards on the first pass.
Reduced operational and regulatory risk
End-to-end support across content creation, translation, and compliance minimizes the inconsistencies that can lead to regulatory pushback or costly delays.
Future-ready operations that grow with you
The life sciences industry is moving toward digital-first regulatory models, and this partnership is designed to support that transition. Whether a company is filing a single submission or managing a global portfolio, the framework grows to meet the need.
Technology That Supports the Partnership
GLOBAL’s commitment to modernizing regulatory work extends beyond writing and consulting. Through GxT (Global Exponential Technologies), their dedicated technology brand, GLOBAL develops AI-powered tools purpose-built for regulatory professionals.
RegWriter™, for example, is an AI-augmented document authoring platform designed to accelerate submission preparation, improve authoring efficiency, and maintain full audit-trail transparency. Similarly, SmartComplaints™ uses machine learning to automate the categorization of post-market complaints against IMDRF Annex codes. These tools follow the same philosophy that drives the partnership itself. They combine deep domain expertise with practical technology to accelerate and improve the reliability of regulatory work. Explore GxT’s full product suite at www.globalxt.io.
A Partnership Built on Years of Collaboration
Vistatec Life Sciences and GLOBAL have collaborated on client engagements for many years. This history built the trust and operational understanding that makes an integrated offering like this possible. The formalized partnership is a natural progression. Both companies expect it will deliver measurable value for their shared clients in the medtech, biotech, and biopharma sectors.
Get Started
If your organization is looking to bring regulatory writing and localization into a single, compliant workflow, we would love to hear from you. Get in touch with the Vistatec Life Sciences team to discover how this partnership can help you accelerate submissions, reduce risk, and achieve global regulatory success.
